Danaher Corporation (FRA:DAP)
177.76
-0.24 (-0.13%)
At close: May 13, 2025, 10:00 PM CET
Revenue by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Former Life Sciences |
Log In |
Log In |
Log In |
Log In |
Former Life Sciences Growth |
Log In |
Log In |
Log In |
Log In |
Diagnostics |
Log In |
Log In |
Log In |
Log In |
Diagnostics Growth |
Log In |
Log In |
Log In |
Log In |
Environmental & Applied Solutions |
Log In |
Log In |
Log In |
Log In |
Environmental & Applied Solutions Growth |
Log In |
Log In |
Log In |
Log In |
Biotechnology |
Log In |
Log In |
Log In |
Log In |
Biotechnology Growth |
Log In |
Log In |
Log In |
Log In |
Life Sciences |
Log In |
Log In |
Log In |
Log In |
Life Sciences Growth |
Log In |
Log In |
Log In |
Log In |
Recurring |
Log In |
Log In |
Log In |
Log In |
Recurring Growth |
Log In |
Log In |
Log In |
Log In |
Non-Recurring |
Log In |
Log In |
Log In |
Log In |
Non-Recurring Growth |
Log In |
Log In |
Log In |
Log In |
EBIT by Product
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Former Life Sciences Operating Income |
Log In |
Log In |
Log In |
Log In |
Former Life Sciences Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
Diagnostics Operating Income |
Log In |
Log In |
Log In |
Log In |
Diagnostics Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
Environmental & Applied Solutions Operating Income |
Log In |
Log In |
Log In |
Log In |
Environmental & Applied Solutions Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
Biotechnology Operating Income |
Log In |
Log In |
Log In |
Log In |
Biotechnology Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
Life Sciences Operating Income |
Log In |
Log In |
Log In |
Log In |
Life Sciences Operating Income Growth |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
North America |
Log In |
Log In |
Log In |
Log In |
North America Growth |
Log In |
Log In |
Log In |
Log In |
Western Europe |
Log In |
Log In |
Log In |
Log In |
Western Europe Growth |
Log In |
Log In |
Log In |
Log In |
Other Developed Markets |
Log In |
Log In |
Log In |
Log In |
Other Developed Markets Growth |
Log In |
Log In |
Log In |
Log In |
High-Growth Markets |
Log In |
Log In |
Log In |
Log In |
High-Growth Markets Growth |
Log In |
Log In |
Log In |
Log In |
Other
Fiscal year is January - December.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Core Sales Growth |
Log In |
Log In |
Log In |
Log In |
Core Sales Growth Ex-Cytiva |
Log In |
Log In |
Log In |
Log In |